Although it is known that genome ploidy contributes to tumour malignancy and inferior survival33,34, we found that clonal mutations of CREBBP/EP300 associated with acquired genome duplication cause relapse and thereby provide a clear genetic mechanism of drug resistance39. This evidence concerns the gene CREBBP and neoplasm.